Ganglioside expression in lung cancer cell lines

被引:58
|
作者
Fuentes, R [1 ]
Allman, R [1 ]
Mason, MD [1 ]
机构
[1] VELINDRE HOSP,RES DEPT,CARDIFF CF4 7XL,S GLAM,WALES
关键词
lung cancer; cell lines; gangliosides; alpha v integrin receptor;
D O I
10.1016/S0169-5002(97)00049-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gangliosides are complex glycolipid constituents of cell membranes. They are involved in many biological functions including cell-cell recognition, cell-matrix attachment, cell growth and cell differentiation. Analysis of tumour associated gangliosides may aid in the characterisation of tumour cells and their degree of malignant transformation. We have characterised a total of eight lung cancer cell lines (four small cell and four non-small cell lung cancer) with respect to ganglioside and alpha v integrin receptor expression. Ganglioside GD3 was detected using the monoclonal antibody R24. Ganglioside GM1 was detected using the beta-subunit of cholera toxin. Ganglioside 9-O-acetyl GD3 and the alpha v integrin receptor were measured using commercially available monoclonal antibodies. Our results indicate that small cell lung cancer cell lines express significant levels of GD3 and 9-O-acetyl GD3. Ganglioside GM1 and alpha v integrin receptor were not specific to any histological subtype. The expression of ganglioside GM1 and GD3 was independent of cell-cycle phase. We conclude that GD3 and 9-O-acetyl GD3 expression may be additional markers of the Small Cell Lung Cancer phenotype, but their significance is unknown. Therefore a characteristic ganglioside pattern cannot be defined according to histological subtype. av integrin receptor expression is not unique to cells expressing GD3. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 50 条
  • [41] An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line
    Kiura, K
    Watarai, S
    Ueoka, H
    Tabata, M
    Gemba, KI
    Aoe, K
    Yamane, H
    Yasuda, T
    Harada, M
    ANTICANCER RESEARCH, 1998, 18 (4C) : 2957 - 2960
  • [42] Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
    Sui, Xin
    Geng, Jian-Hao
    Yu, Hui-Ming
    Li, Yong-Heng
    Wang, Wei-Hu
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (150):
  • [43] Multidrug resistance in small cell lung cancer cell lines
    Palaniyandi, Kanagaraj
    Zhao, Qing
    Hou, Yuexian
    Chang, Xiubao
    CANCER RESEARCH, 2009, 69
  • [44] Characterization of Lung Cancer Cell Lines by Single Cell Analysis
    Seeber, Frouke Sophie
    Hinze, Anna
    Hochhaus, Andreas
    Clement, Joachim
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 237 - 237
  • [45] Differential gene expression profiles of radioresistant lung cancer cell lines established by fractionated irradiation
    Duk, Choi Y.
    Hui, Jeong E.
    Woo, Min B.
    Kim, Y.
    Woo, Nam S.
    Ja, Ahn S.
    Chul, Kim Y.
    Choi, C.
    VIRCHOWS ARCHIV, 2009, 455 : 342 - 342
  • [46] The immune checkpoint, HVEM, is associated with PDL1 expression in lung cancer cell lines
    Ren, Shengxiang
    Amar, Nadav
    Yu, Hui
    Rivard, Christopher
    Ellison, Kim
    Rozeboom, Leslie
    Hirsch, Fred R.
    CANCER RESEARCH, 2018, 78 (13)
  • [47] GANGLIOSIDE EXPRESSION IN PEDIATRIC BRAIN TUMOR CELL LINES AND DEVELOPMENT OF ANTIGANGLIOSIDE scFv BY AFFINITY MATURATION
    Piao, Hailan
    Pegram, Charles N.
    Kuan, Chien-Tsun
    Bigner, Darell D.
    NEURO-ONCOLOGY, 2011, 13 : I7 - I7
  • [48] Collagenase expression in ovarian cancer cell lines
    Moore, DH
    Allison, B
    Look, KY
    Sutton, GP
    Bigsby, RM
    GYNECOLOGIC ONCOLOGY, 1997, 65 (01) : 78 - 82
  • [49] Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines
    Fujita, J
    Ohtsuki, Y
    Bandoh, S
    Ueda, Y
    Kubo, A
    Tojo, Y
    Yamaji, Y
    Ishida, T
    LUNG CANCER, 2003, 39 (01) : 31 - 36
  • [50] Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines
    Matsubara, S
    Yamaji, Y
    Sato, M
    Fujita, J
    Takahara, J
    BRITISH JOURNAL OF CANCER, 1996, 74 (09) : 1419 - 1422